|
SNIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33226762955019E-15 |
| Normal-vs-Stage2 |
1.68239866482622E-11 |
| Normal-vs-Stage3 |
2.66453525910038E-15 |
| Normal-vs-Stage4 |
1.63491442606301E-12 |
| Stage1-vs-Stage2 |
1.762400E-01 |
| Stage1-vs-Stage3 |
3.763800E-01 |
| Stage1-vs-Stage4 |
3.725700E-02 |
| Stage2-vs-Stage3 |
4.917000E-01 |
| Stage2-vs-Stage4 |
7.936600E-01 |
| Stage3-vs-Stage4 |
2.761800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.92030000001342E-06 |
| Normal-vs-Asian |
2.94720003957138E-09 |
| Caucasian-vs-AfricanAmerican |
6.010600E-01 |
| Caucasian-vs-Asian |
6.196400E-01 |
| AfricanAmerican-vs-Asian |
8.967000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.798200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68698388591793E-12 |
| Normal-vs-Age(41-60Yrs) |
3.88578058618805E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.379200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.525200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.164200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.947800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.880150E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.480000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.923800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.259100E-03 |
| Classical-VS-Follicular |
3.06530000271366E-08 |
| Classical-VS-Other |
1.380600E-01 |
| Classical-VS-Normal |
1.63447033685316E-12 |
| Tall-VS-Follicular |
1.000400E-01 |
| Tall-VS-Other |
7.459600E-01 |
| Tall-VS-Normal |
1.38988820452823E-12 |
| Follicular-VS-Other |
7.397400E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
1.219580E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.60458321577062E-13 |
| N0-vs-N1 |
7.334800E-01 |
|
|
